News

12 August 2022

The Ministry of Health Continues to Encourage the Use of Phytopharmaceuticals in Health Service Facilities

The government primarily focuses on developing phytopharmaceuticals to create a system of health resilience and domestic pharmaceutical self-reliance. Launching the Phytopharmaca Formulary and promoting its usage in medical institutions are examples of the government's commitment to fostering the use of phytopharmaceuticals. The Director General of Pharmaceuticals and Medical Devices at…
5 August 2022

Dexa Group's Commitment to Encourage the Production of Natural Medicine Raw Materials for National Independence

With more than 28000 plant species and 2,848 medicinal plants, Indonesia has the second-highest biodiversity in the world. Its natural resources hold tremendous promise for developing phytopharmaceuticals and herbal medicines, including Indonesia Indigenous Modern Medicine (IIMM). Penny K. Lukito, head of the Food and Drug Supervisory Agency (BPOM), stated that…
1 August 2022

Dexa Award Science Scholarship 2022 Stimulates Innovation to Build Health Independence

The Indonesian government continues to encourage the resilience and independence of the healthcare industry, as imports dominate 90% of its domestic pharmaceutical raw materials and health spending. In addition, 88% of medical device transactions through electronic catalogs (e-catalogs) are imported products. Meanwhile, research and development funds are only about 0.2%…
13 May 2022

HerbaASIMOR Products Aid in the Reduction of Stunting Rates

According to the Indonesia Nutrition Status Survey (SSGI), in 2021, the prevalence of stunting in Indonesia will be 24.4 percent, a 6.4 percent decrease from 30.8 percent in 2018. To meet the goal of reducing stunting prevalence to 14 percent by 2024, the Population Agency and the National Family Planning…
2 May 2022

Dexa Group Donates Cancer Medicines to aid Sri Lanka's Economic and Health Crisis

The economic crisis that hit Sri Lanka caused a lack of supplies of medicines in the country and encouraged the concern of pharmaceutical companies in Indonesia to donate medicines and medical devices, including Dexa Group. The World Health Organization authorities submitted the request to the Indonesian government through the Indonesian…
28 March 2022

Dexa Group Optimizing the Potential of the Domestic Market to Improve the Quality of Life for the Elderly

As the world's fifth-largest elderly population, Indonesia offers a substantial market potential for health goods and services for the elderly. As a result, to enhance the quality of life of the elderly in Indonesia, innovation and research in geriatrics, particularly by native researchers, must be supported. This statement was conveyed…
23 March 2022

Dexa Group's High TKDN Products Become Pharmaceutical Products in Business Matching

Dexa Group is one of the pharmaceutical companies that take part in Business Matching activities organized by the Ministry of Industry to maximize the purchase of domestic products. The event, which took place on the 22nd until 24th of March 2022 in Nusa Dua, Bali, continued the Bangga Buatan Indonesia…
18 March 2022

Dexa Group Attends the Inauguration of the 'Pengabdian Dokter Indonesia' Monument in Memory of Indonesian Doctors Who Served During the Pandemic

The Indonesian Doctors Association inaugurated the erection of a monument named "Pengabdian Dokter Indonesia" to remember the services of doctors who died to preserve the lives of Indonesians while dealing with COVID-19. Dexa Group took part in the establishment and inauguration of the monument, which took place on Thursday, March…
9 March 2022

Indonesian Indigenous Modern Medicines, Green Pharmacy Implementation for Strengthening Global Health at the T20 Forum

The local healthcare industry is the backbone of healthcare services, serving as a solid support structure for the country's requirements. Green Pharmacy is a notion that became the idea of the Indonesian pharmaceutical business by exploiting natural biodiversity in the form of Indonesian Indigenous Modern Medicines items manufactured using modern…
25 February 2022

Journey with Pinisi, OMAI Expedition Donates Medicines for Public Health in South Sulawesi

To improve public health and handle stunting issues in South Sulawesi, Dexa Group donated Indonesian Indigenous Modern Medicines (OMAI). The OMAI donation was symbolically handed over during the OMAI Expedition at the Bangga Buatan Indonesia & Bangga Wisata Indonesia Sulawesi Selatan 2022 South Sulawesi 2022 event at Losari Beach Pavilion,…